Danville Neuropathy Center Inc | |
919 San Ramon Valley Blvd Ste 255 Danville CA 94526-4051 | |
(925) 854-2089 | |
Not Available |
Full Name | Danville Neuropathy Center Inc |
---|---|
Speciality | Family Medicine |
Location | 919 San Ramon Valley Blvd Ste 255, Danville, California |
Authorized Official Name and Position | John Filippini (OWNER, AUTHORIZED OFFICIAL) |
Authorized Official Contact | 9258542089 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Danville Neuropathy Center Inc 919 San Ramon Valley Blvd Ste 255 Danville CA 94526-4051 Ph: () - | Danville Neuropathy Center Inc 919 San Ramon Valley Blvd Ste 255 Danville CA 94526-4051 Ph: (925) 854-2089 |
NPI Number | 1588281406 |
---|---|
Provider Enumeration Date | 06/26/2020 |
Last Update Date | 06/26/2020 |
Medicare PECOS PAC ID | 2567888241 |
---|---|
Medicare Enrollment ID | O20200812000651 |
News Archive
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
In an analysis that included data on more than 10 million Medicare beneficiaries admitted to acute care hospitals with a heart attack, congestive heart failure, or pneumonia between 2002 and 2010, 30-day mortality rates for those admitted to critical access hospitals (designated hospitals that provide inpatient care to individuals living in rural communities) increased during this time period compared with patients admitted to other acute care hospitals, according to a study in the April 3 issue of JAMA.
Leakage of urine when a person coughs or sneezes (stress incontinence) or from involuntary contraction of the bladder (urge incontinence) is a common problem for people living in the community.
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
› Verified 2 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1588281406 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
Provider Name | Janet M Hall |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1538390687 PECOS PAC ID: 4082877170 Enrollment ID: I20120530000480 |
News Archive
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
In an analysis that included data on more than 10 million Medicare beneficiaries admitted to acute care hospitals with a heart attack, congestive heart failure, or pneumonia between 2002 and 2010, 30-day mortality rates for those admitted to critical access hospitals (designated hospitals that provide inpatient care to individuals living in rural communities) increased during this time period compared with patients admitted to other acute care hospitals, according to a study in the April 3 issue of JAMA.
Leakage of urine when a person coughs or sneezes (stress incontinence) or from involuntary contraction of the bladder (urge incontinence) is a common problem for people living in the community.
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
› Verified 2 days ago
Provider Name | Hannah Krizzia Rivera |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1720627185 PECOS PAC ID: 6800213208 Enrollment ID: I20200831002771 |
News Archive
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
In an analysis that included data on more than 10 million Medicare beneficiaries admitted to acute care hospitals with a heart attack, congestive heart failure, or pneumonia between 2002 and 2010, 30-day mortality rates for those admitted to critical access hospitals (designated hospitals that provide inpatient care to individuals living in rural communities) increased during this time period compared with patients admitted to other acute care hospitals, according to a study in the April 3 issue of JAMA.
Leakage of urine when a person coughs or sneezes (stress incontinence) or from involuntary contraction of the bladder (urge incontinence) is a common problem for people living in the community.
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
› Verified 2 days ago
News Archive
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
In an analysis that included data on more than 10 million Medicare beneficiaries admitted to acute care hospitals with a heart attack, congestive heart failure, or pneumonia between 2002 and 2010, 30-day mortality rates for those admitted to critical access hospitals (designated hospitals that provide inpatient care to individuals living in rural communities) increased during this time period compared with patients admitted to other acute care hospitals, according to a study in the April 3 issue of JAMA.
Leakage of urine when a person coughs or sneezes (stress incontinence) or from involuntary contraction of the bladder (urge incontinence) is a common problem for people living in the community.
At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.
› Verified 2 days ago
Dr Tiffany M King, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 336 Diablo Rd, Danville, CA 94526 Phone: 925-837-4676 | |
Okamura Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1320 El Capitan Dr, Suite 310, Danville, CA 94526 Phone: 925-244-9355 | |
John Muir Physician Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 907 San Ramon Valley Blvd, Suite 202, Danville, CA 94526 Phone: 925-837-4202 Fax: 925-837-2514 | |
Rezolv Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9000 Crow Canyon Rd Ste S360, Danville, CA 94506 Phone: 650-438-8983 | |
Michael J Schierman Md A Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4165 Blackhawk Plaza Cir, Suite 265, Danville, CA 94506 Phone: 925-648-7140 Fax: 925-648-0878 | |
Bay Area Surgical Specialists, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 913 San Ramon Valley Blvd, Suite 186, Danville, CA 94526 Phone: 925-984-2622 Fax: 925-984-2423 | |
East Bay Premier Medical Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2090 Lusitano St, Danville, CA 94506 Phone: 626-627-1234 |